Synthesis and antidepressant-like activity evaluation of sulphonamides and sulphonyl-hydrazones

Bioorganic and Medicinal Chemistry

Volumn 19, Issue 14, 2011, Pages 4295-4306

  De Oliveira, Kely Navakoski ^a   Costa, Philipe ^a   Santin, José Roberto ^a   Mazzambani, Leonor ^a   Bürger, Cristiani ^a   Mora, Cristiano ^a   Nunes, Ricardo José ^a   De Souza, Márcia Maria ^a  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

Author keywords

Antidepressant effect; Cyclic imides; Sulphonamides; Sulphonyl hydrazones

Indexed keywords

2 [4 (MORPHOLIN 1 YLSULFONYL)BENZYL] 1H BENZO[DE]ISOQUINOLINE 1,3(2H) DIONE; 2 [4 (PYRROLIDIN 1 YLSULFONYL)BENZYL] 1H BENZO[DE]ISOQUINOLINE 1,3(2H) DIONE; 2 BENZYL 1H BENZO[DE]ISOQUINOLINE 1,3(2H)DIONE; 2 BENZYL 1H ISOINDOL 1,3(2H) DIONE; 2 BENZYL 6 CHLORO 1H BENZO[DE]ISOQUINOLINE 1,3(2H)DIONE; 4 [(1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL)METHYL] N' [(3 METHOXY 4 HYDROXYPHENYL)METHYLENE]BENZENESULPHONYL HYDRAZONE; 4 [(1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL)METHYL] N' [(4 NITROPHENYL)METHYLENE]BENZENESULPHONYL HYDRAZONE; 4 [(1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL)METHYL]BENZENSULPHONYL CHLORIDE; 4 [(1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL)METHYL]BENZENSULPHONYL HYDRAZIDE; 4 [(1,3 DIOXO 1H BENZO[DE]ISOQUINOLIN 2(3H) YL)METHYL]BENZENESULPHONYL CHLORIDE; 4 [(1,3 DIOXO 1H BENZO[DE]ISOQUINOLIN 2(3H) YL)METHYL]BENZENESULPHONYL HYDRAZIDE; 4 [(6 CHLORO 1,3 DIOXO 1H BENZO[DE]ISOQUINOLIN 2(3H) YL)METHYL]BENZENESULPHONYL CHLORIDE; 4 [2 (1,3 DIOXO 1H BENZO[DE]ISOQUINOLINE 2(3H) YL)METHYL] N' [(3 METHOXY 4 HYDROXYPHENYL)METHYLENE]BENZENESULPHONYL HYDRAZONE; 4 CHLORO 1,8 N (4 CHLOROSULFONYL)PHENETHYLNAPHTHALIMIDA; 4 CHLORO 1,8 N PHENYLETHYLNAPHTHALIMIDE; 6 CHLORO 2 [4 (PYRROLIDIN 1 YLSULPHONYL)PHENETHYL] 1H BENZO[DE]ISOQUINOLINE 1,3(2H) DIONE; ANTIDEPRESSANT AGENT; FLUOXETINE; HYDRAZONE DERIVATIVE; IMIPRAMINE; SULFONAMIDE; SULPHONYL HYDRAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; EXPERIMENTAL TEST; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TAIL SUSPENSION TEST;

ANIMALS; ANTIDEPRESSIVE AGENTS; HYDRAZONES; MALE; MICE; MOLECULAR STRUCTURE; MOTOR ACTIVITY; STEREOISOMERISM; STRESS, PSYCHOLOGICAL; SULFONAMIDES; SWIMMING;

MUS;

EID: 79959947636     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2011.05.056     Document Type: Article

References (43)

1. R.H. Belmaker, and G. Agam N. Eng. J. Med. 358 2008 55
2. M. Zandio, M. Ferrín, and M.J. Cuesta An. Sist. Sanit. Navar. 25 2002 43
3. S. Rosenzweig-Lipson, C.E. Beyer, Z.A. Hughes, X. Khawaja, S.J. Rajarao, J.E. Malberg, Z. Rahman, R.H. Ring, and L.E. Schechter Pharmacol. Ther. 113 2007 134
4. P.V. Tran, F.P. Bymaster, R.K. Mcnamara, and W.Z. Potter J. Clin. Psychopharmacol. 23 2003 78
5. J.F. Cryan, A. Markou, and I. Lucki Trends Pharmacol. Sci. 23 2002 238
6. O. Berton, and E.J. Nestler Nat. Rev. Neurosci. 7 2006 137
7. V. Cechinel Filho, F. de Campos, R. Corrêa, R.A. Yunes, and R.J. Nunes Quím. Nova 26 2003 230
8. R.R. Goehring, T.D. Greenwood, J.S. Pisipati, and J.F. Wolfe J. Pharm. Sci. 17 2006 790
9. J. Kossakowski, and M. Jarocka Il Farmaco 56 2001 785
10. F.S. Duarte, E.S. Andrade, R.A. Vieira, M. Uieara, R.J. Nunes, and T.C.M. de Lima Bioorg. Med. Chem. 14 2006 5397
11. J. Kossakowski, M. Krawiecka, and B. Kuran Molecules 11 2006 615
12. M.H. Paluchowska, R. Bugno, B. Duszynska, E. Tatarczynska, A. Nikiforuk, T. Lenda, and E. Chojnacka-Wojcik Bioorg. Med. Chem. 15 2007 7116
13. K. Yabuuchi, R. Tagashira, and Y. Ohno Biogenic Amines 18 2004 319
14. G. Pineyro, and P. Blier Pharmacol. Rev. 51 1999 533
15. J.P. Redrobe, C.P. MacSweeney, and M. Bourin Eur. J. Pharmacol. 318 1996 213
16. J.D. Scott, M.W. Miller, S.W. Li, S.I. Lin, H.A. Vaccaro, L. Hong, D.E. Mullins, M. Guzzi, J. Weinstein, R.A. Hodgson, G.B. Varty, A.W. Stamford, T.Y. Chan, B.A. McKittrick, W.J. Greenlee, T. Priestley, and E.M. Parker Bioorg. Med. Chem. Lett. 19 2009 6018
17. F. Chimenti, E. Maccioni, D. Secci, A. Bolasco, P. Chimenti, A. Granese, O. Befani, P. Turini, S. Alcaro, F. Ortuso, M.C. Cardia, and S.J. Distinto Med. Chem. 50 2007 707
18. R.C. Kessler, K.A. Mc Gonagle, C.B. Nelson, M. Hughes, M. Swartz, and D.G.J. Blazer Affect. Disord. 30 1994 15
19. J.J. Schildkraut Am. J. Psychiatry 122 1965 509
20. R.S. Duman, O.R. Heninger, and E.L. Nestler Arch. Gen. Psychiatry 54 1997 597
21. P. Blier, and N.M. Ward Biol. Psychiatry. 53 2003 193
22. R.D. Porsolt, M. Le Pichon, and M. Jalfre Nature 266 1977 730
23. R.D. Porsolt, A. Bertin, and M. Jalfre Arch. Int. Pharmacodyn. Ther. 229 1977 327
24. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Eur. J. Pharmacol. 47 1978 379
25. K. Matthews, D. Christmas, J. Swan, and E. Sorrell Neurosci. Biobehav. Rev. 29 2005 503
26. L. Steru, R. Chermat, B. Thierry, and P. Simon Psychopharmacology (Berl) 85 1985 367
27. D.G. Machado, M.P. Kaster, R.W. Binfaré, M. Dias, A.R. Santos, M.G. Pizzolatti, I.M. Brighente, and A.L. Rodrigues Prog. Neuropsychopharmacol. Biol. Psychiatry 2 2007 421
28. H. Anisman, and K. Matheson Neurosci. Biobehav. Rev. 29 2005 525
29. M. Bourin, A.J. Fiocco, and F. Clenet Hum. Psychopharmacol. 16 2001 9
30. M.D. Lapiz-Bluhm, C.O. Bondi, J. Doyen, G.A. Rodriguez, T. Bédard-Arana, and D.A. Morilak J. Neuroendocrinol. 20 2008 1115
31. A.V. Kalueff, M. Wheaton, and D.L. Murphy Behav. Brain Res. 179 2007 18
32. A. Wesolowska Pharmacol. Rep. 59 2007 664
33. X. Li, J.P. Tizzano, K. Griffey, M. Clay, T. Lindstrom, and P. Skolnick Neuropharmacology 40 2001 1028
34. K.N. Oliveira, and R.J. Nunes Synth. Commun. 36 2006 3401
35. K.N. Oliveira, L.D. Chiaradia, P.G.A. Martins, A. Mascarello, M.N.S. Cordeiro, R.V.C. Guido, A.D. Andricopulo, R.A. Yunes, R.J. Nunes, J. Vernal, and H. Terenzi Med. Chem. Commun. 2 2011 500
36. A. Takács, P. Ács, and L. Kollár Tetrahedron 64 2008 983
37. Senshu, H. Patent language unavailable, FR 1405776 19650709, 1965; 16 pp.
38. Mederski, W.; Devant, R.; Barnickel, G.; Bernotat-Danielowski, S.; Melzer, G.; Raddatz, P.; Wu, Z.; Dhanoa, D.; Soll, R.; Rinker, J.; Graybill, T. (Merck Patent G.m.b.H., Germany). PCT Int. Appl., 2000; 135 pp. CODEN: PIXXD2 WO 2000031039 A1 20000602.
39. T. Vidal, A. Petit, A. Loupy, and R.N. Gedye Tetrahedron 56 2000 5473
40. F.H. Bergeim, and W. Braker J. Am. Chem. Soc. 66 1944 1459
41. Y. Sugimoto, S. Furutani, K. Nishimura, A. Itoh, C. Tanahashi, H. Nakajima, H. Oshiro, S. Sun, and S. Yamada Eur. J. Pharmacol. 62 2010 6730
42. J.F. Cryan, and I. Lucki Eur. J. Pharmacol. 409 2000 295
43. L. Broto, A.M. Barr, and B.B. Gorzalka Eur. J. Pharmacol. 402 2000 93